AKT1 and colorectal cancer: (86) Similarly, in colorectal cancer models, promethazine has been shown to reduce p-PI3K and phosphorylated AKT (p-AKT) levels, suppress cell proliferation, and induce apoptosis by downregulating B-cell lymphoma 2 (Bcl-2) and activating caspase-3 (87).